Refeyn launches KaritroMP for rapid and reproducible characterization of large viral vectors

My­robal­an Ther­a­peu­tics has raised $24 mil­lion to en­ter the clin­ic with one of its four CNS ther­a­peu­tic can­di­dates, with the goal of ei­ther re­pair­ing or

However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve